Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biotechnology is enjoying one of its strongest years in recent times, which is mostly fueled by a rebound in capital markets, ...

Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.

We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Jade Biosciences, Inc. (NASDAQ:JBIO) ...

They have at least one thing in common: An exciting pipeline.

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector. Biotech stocks lagged the broader market in ...

On Wednesday, September 24, the share price of a little-known biotech company based in Amsterdam suddenly surged 247.7%. The company, uniQure N.V. (QURE), saw its market cap surge to $2.76 billion ...